Early hopes around a treatment can change once stronger evidence appears. Sometimes benefits are smaller than first believed. Other times the real value is different than expected.
New research suggests Paxlovid may not lower hospitalization or death rates in certain vaccinated high-risk adults. However, it may still help people recover faster. The findings came from two randomized controlled trials, considered a strong form of medical evidence. Researchers studied people who had received COVID-19 vaccines and were still considered at higher risk for complications.










